A small-molecule self-assembled nano-prodrug for enhanced therapy of cancer stem cell-enriched pancreatic ductal adenocarcinoma
- 11 July 2026
- journal article
- Published by Elsevier in Acta Biomaterialia
- Vol. 220, 245-260
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (82503536)
- National Natural Science Foundation of China (82425055)
- National Natural Science Foundation of China (82504685)
This publication has 54 references indexed in Scilit:
- Tumor microenvironment interactions with cancer stem cells in pancreatic ductal adenocarcinoma2023
- Protocol for Indocyanine Green Angiography2022
- Pancreatic CancerJAMA, 2021
- Stimulus-responsive liposomes for biomedical applicationsDrug Discovery Today, 2021
- Pharmacokinetics of gemcitabine and its amino acid ester prodrug following intravenous and oral administrations in miceBiochemical Pharmacology, 2020
- Identification and Validation of a Biomarker Signature in Patients With Resectable Pancreatic Cancer via Genome-Wide Screening for Functional Genetic VariantsJAMA Surgery, 2019
- Pancreatic cancer: French clinical practice guidelines for diagnosis, treatment and follow-up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, ACHBT, AFC)Digestive and Liver Disease, 2018
- N,N-diethylaminobenzaldehyde (DEAB) as a substrate and mechanism-based inhibitor for human ALDH isoenzymesChemico-Biological Interactions, 2015
- Identification of Human Pancreatic Cancer Stem Cells2009
- Model-Based Drug Development: The Road to Quantitative PharmacologyJournal of Pharmacokinetics and Pharmacodynamics, 2006